Literature DB >> 1742731

DNA damage and differential cytotoxicity produced in human carcinoma cells by CC-1065 analogues, U-73,975 and U-77,779.

C S Lee1, N W Gibson.   

Abstract

U-73,975 (U-73) and U-77,779 (U-77), two analogues of the cyclopropylpyrroloindole antitumor antibiotic CC-1065, are promising novel chemotherapeutic agents which are known to alkylate the N3 position of adenine in a sequence-selective manner. The concentration of U-73 required to produce a 1 log cell kill in 6 human tumor cell lines varied from 20-60 pM. U-77 was more cytotoxic than U-73, with the concentrations required for a 1 log cell kill ranging from 1-20 pM. The cytotoxicity of U-73 and U-77 was found to be independent of the guanine O6-alkyltransferase phenotype. The sensitivity of the BE and HT-29 human colon carcinoma cells was increased when the time of drug exposure was increased from 2 to 6 h. DNA interstrand cross-links, as measured by the technique of alkaline elution, could only be detected when HT-29 or BE cells were exposed to extremely high concentrations of U-77 for 6 h. No other forms of DNA damage were detected in genomic DNA with either compound. U-77 was also found to induce DNA interstrand cross-links in naked DNA, as measured by an agarose gel method. The rate of interstrand cross-linking was extremely rapid with the "second-arm" of the cross-link being completed within 2 h. The mechanism by which these cyclopropylpyrroloindole compounds elicit their cytotoxicity, however, remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1742731

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Preclinical pharmacology of bizelesin, a potent bifunctional analog of the DNA-binding antibiotic CC-1065.

Authors:  D L Walker; J M Reid; M M Ames
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  A quantitative mass spectrometry-based approach for assessing the repair of 8-methoxypsoralen-induced DNA interstrand cross-links and monoadducts in mammalian cells.

Authors:  Shuo Liu; Yinsheng Wang
Journal:  Anal Chem       Date:  2013-07-03       Impact factor: 6.986

3.  Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule.

Authors:  A Awada; C J Punt; M J Piccart; O Van Tellingen; L Van Manen; J Kerger; Y Groot; J Wanders; J Verweij; D J Wagener
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

4.  Differential effect of duocarmycin A and its novel derivative DU-86 on DNA strand breaks in HeLa S3 cells.

Authors:  A Okamoto; A Asai; H Saito; M Okabe; K Gomi
Journal:  Jpn J Cancer Res       Date:  1994-12

5.  Aberrant sporogonic development of Dmc1 (a meiotic recombinase) deficient Plasmodium berghei parasites.

Authors:  Godfree Mlambo; Isabelle Coppens; Nirbhay Kumar
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

6.  A novel antitumor antibiotic, KW-2189 is activated by carboxyl esterase and induces DNA strand breaks in human small cell lung cancer cells.

Authors:  H Ogasawara; K Nishio; Y Takeda; T Ohmori; N Kubota; Y Funayama; T Ohira; Y Kuraishi; Y Isogai; N Saijo
Journal:  Jpn J Cancer Res       Date:  1994-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.